Purchase Order 36C26125P1616
Award Date
9/23/25
Potential Completion Date
11/23/25
Potential Value
$19K
Federal Agency
Veterans Integrated Service Network 21
Awardee
Biologics, Inc.
Ultimate Awardee
Mckesson Corporation
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cary, NC 27513, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $20,432.27 firm fixed-price purchase order awarded by the Veterans Integrated Service Network 19 (VISN 19), a civilian agency, to Biologics, Inc., a subsidiary of McKesson Corporation, for the emergency procurement of the cancer medication Lenalidomide. The contract has an ultimate completion date of September 30, 2025 and was awarded on August 21, 2025. Biologics, Inc. is a for-profit pharmaceutical company that specializes in delivering critical medical treatments, particularly...
This is a firm fixed-price purchase order contract awarded by the Federal Medical Center Carswell, a civilian agency, to Biologics, Inc., a subsidiary of McKesson Corporation, for the supply of cancer drugs and biologics during fiscal year 2025. The contract has a ceiling value of $22,061.05 and an ultimate completion date of May 31, 2025. There is no set-aside designation for this contract, indicating open competition. Biologics, Inc. is a for-profit pharmaceutical company that specializes in...
This is a firm fixed-price purchase order for $91,279.43 awarded by the Veterans Integrated Service Network 22, a component of the Department of Veterans Affairs (VA), to Biologics, Inc. to provide the cancer medication Lynparza on an emergency basis. The contract period was from November 6, 2015 to September 30, 2016. This contract was not set aside for any specific business category. Biologics, Inc. is a for-profit pharmaceutical company that has provided specialty medications to various...
This is a firm fixed-price purchase order contract awarded by the Federal Medical Center Carswell, a civilian agency, to Biologics, Inc., a subsidiary of McKesson Corporation. The $22,061.05 contract is for the delivery of cancer drugs and biologics to the agency in July 2025. The contract has no set-aside designation, indicating open competition. As a specialized pharmaceutical provider, Biologics, Inc. has a history of delivering critical medical treatments, particularly cancer medications, to...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 19 to Biologics, Inc., a for-profit pharmaceutical provider, for $99,184.84. The contract is for express pharmacy orders, with a period of performance ending on September 30, 2017. Biologics, Inc. has provided specialty medications such as cancer treatments to VA medical centers and Bureau of Prisons facilities in the past. This award does not have a set-aside...
This is a $22,061.05 firm fixed-price purchase order awarded by the Federal Medical Center Carswell, a civilian agency, to Biologics, Inc., a subsidiary of McKesson Corporation, for the supply of cancer drugs and biologics in fiscal year 2025. The contract has no set-aside designation, indicating open competition. Biologics, Inc. is a pharmaceutical company focused on delivering critical medical treatments, particularly cancer medications, to various federal healthcare and correctional...
The U.S. Department of Veterans Affairs (VA) awarded a firm fixed-price purchase order to Mckesson Plasma And Biologics LLC, a subsidiary of Mckesson Corporation, for the delivery of belzutifan 40mg capsules. The contract, valued at $22,051.39, has an ultimate completion date of April 30, 2025. The award was made through the Veterans Integrated Service Network 2 (VISN 2), a regional network within the VA's healthcare system. The contract does not have a set-aside designation. Mckesson Plasma And...
This is a delivery order contract awarded by the Veterans Integrated Service Network 21 (VISN 21), a civilian agency, to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract is for the supply of the drug LENALIDOMIDE, with a firm fixed price and a ceiling value of $10,397.52. The contract has an ultimate completion date of October 17, 2025. Exelan Pharmaceuticals is a key supplier of pharmaceutical products to various...
This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) to Mckesson Corporation, a healthcare services and information technology company, for the delivery of the pharmaceutical drug Bicnu Vial 100mg + Diluent, 3ml - Carmustine, 100mg/Vial. The contract has a ceiling value of $112,358.00 and a completion date of July 22, 2016. No set-aside designation was used. Mckesson is a prime contractor that has received multiple awards from the VA and Department of...
This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 20 to McKessson Corporation, a healthcare services and information technology company. The contract is for the delivery of Melphalan Hydrochloride 50mg vials, a pharmaceutical product. The contract has a ceiling value of $101,056.68 and an ultimate completion date of March 22, 2017. The contract was not set aside for any specific business type. McKessson...